glp 1 mimetic GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome rx_of_diabetes [TUSOM | Pharmwiki]
Pay in 4 interest-free payments of $6.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
![glp 1 mimetic GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome rx_of_diabetes [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/dpp4.png?w=600&tok=f9724b)
![glp 1 mimetic GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome rx_of_diabetes [TUSOM | Pharmwiki]](https://cdn.lecturio.com/assets/Nursing_CS_Injectable_Non-Insulin_Medication_Management_of_Diabetes-02.jpg)
![glp 1 mimetic GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome rx_of_diabetes [TUSOM | Pharmwiki]](https://globalrph.com/wp-content/images/incretin-dpp4.jpg)
![glp 1 mimetic GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome rx_of_diabetes [TUSOM | Pharmwiki]](https://www.emjreviews.com/wp-content/uploads/2022/10/Figure-2-Pleiotropic-actions-of-glucagon-like-peptide-1..jpg)




















